Studies › 2006 · Last reviewed 2026-05-16

Delemarre-van de Waal & Cohen-Kettenis (2006)

Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol. 2006;155(S1):S131–7.

Summary

This 2006 article describes the Dutch Protocol. According to its abstract, adolescents are eligible for puberty suppression if they meet the DSM-IV criteria for gender identity disorder, have had lifelong extreme gender dysphoria, are psychologically stable and live in a supportive environment. Treatment consists of a GnRH analogue (GnRHa) from breast stages B2-3 and genital stages G3-4; cross-sex hormones can be added from age 16 (source).

1. Content of the publication

  • Diagnostic criteria according to DSM-IV-TR.
  • Inclusion criteria — see /protocol/inclusion-criteria/.
  • Preliminary findings on height growth, bone maturation and bone density during puberty suppression.

2. Methodological status

The publication is a clinical protocol, not an empirical study: it mainly describes the method; the abstract only mentions preliminary findings on growth and bone density. Outcome data followed later: in 2011 (de Vries et al., a prospective follow-up of the first 70 adolescents who received puberty blockers; source) and in 2014 (de Vries et al., 55 young adults; source).

Critical note

This article describes the protocol and is not an outcome study. It appeared in 2006 in a supplement of the European Journal of Endocrinology, not of the Endocrine Society. According to Biggs, the main evidence for the Dutch Protocol came from one longitudinal study of 70 adolescents (de Vries et al., 2011), whose favourable outcomes rested on a small number of observations (source).1

See also

Footnotes

  1. Biggs M. The Dutch Protocol for juvenile transsexuals: origins and evidence. J Sex Marital Ther. 2023;49(4):348–68.